31 min listen
Immunotherapy doesn't impact COVID mortality, breast cancer screening for the developing world, and 2 FDA approvals
FromBlood & Cancer
Immunotherapy doesn't impact COVID mortality, breast cancer screening for the developing world, and 2 FDA approvals
FromBlood & Cancer
ratings:
Length:
13 minutes
Released:
Aug 11, 2020
Format:
Podcast episode
Description
Subscribe to Blood & Cancer: Apple Podcasts, Spotify, Google Podcasts This week in HemOnc news: Study: Immune checkpoint inhibitors don't increase risk of death in cancer patients with COVID-19: https://bit.ly/2PEttQa System provides 'faster, less invasive' method for breast cancer detection: https://bit.ly/3achral Source: https://bit.ly/3gN507j FDA approves belantamab in relapsed/refractory multiple myeloma: https://bit.ly/3ksQtQu FDA approves new drug for diffuse large B-cell lymphoma: https://bit.ly/3kvoIXn For more MDedge Podcasts, click this link: http://bit.ly/2CfnY52 Email the show: podcasts@mdedge.com Follow Dr. David Henry on Twitter @DavidHenryMD
Released:
Aug 11, 2020
Format:
Podcast episode
Titles in the series (100)
ASH19 special report: Blood & Cancer takes you behind the podium at the American Society of Hematology annual meeting for an in-depth look at the latest developments in anemia and myelodysplastic syndrome, chimeric antigen receptor (CAR) T-cell therapy for mantle cell... by Blood & Cancer